SynapDx Obtains New Financing

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    153 Cordaville Road Southborough, MA 01772
  • Company Description
    SynapDx was formed to develop and commercialize blood-based diagnostic tests for the early detection of autism.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    The funding will support the ongoing clinical development of SynapDx’s breakthrough blood-based autism spectrum disorder (ASD) diagnostic test, designed to help clinicians identify children with autism earlier than they do today.
  • M&A Terms
  • Venture Investor
    The Kraft Group

Trending on Xconomy